<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02448498</url>
  </required_header>
  <id_info>
    <org_study_id>32113</org_study_id>
    <nct_id>NCT02448498</nct_id>
  </id_info>
  <brief_title>Strength Training Regimen for Normal Weight Diabetics</brief_title>
  <acronym>STRONG-D</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      The Strength Training Regimen in Normal Weight Diabetics (STRONG-D) study will examine the&#xD;
      effectiveness of different exercise regimen types in controlling diabetes for the normal&#xD;
      weight type 2 diabetes population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the STRONG-D study, participants are randomly assigned to strength training, aerobic&#xD;
      training or a combined strength and aerobic training group. Participants in the exercise&#xD;
      group will attend exercise sessions over the course of 9 months at the YMCA. Participants&#xD;
      will have opportunities to engage in other activities such as educational run-in visits that&#xD;
      will allow for measurement of hemoglobin A1c and emphasize the importance of exercise in&#xD;
      improving Type 2 diabetes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">July 2020</completion_date>
  <primary_completion_date type="Actual">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hemoglobin A1c across study visits</measure>
    <time_frame>Baseline, monthly (for 9 months), 9-Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in body composition across study visits, as measured using DEXA</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in waist circumference across study visits</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure across study visits</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body weight across study visits</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cardiorespiratory fitness, as measured by 6-minute walk test</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle strength and endurance, as measured by Biodex strength testing</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Dietary Intake, as measured by Food Frequency Questionnaire</measure>
    <time_frame>Baseline, 9-Months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">289</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Strength Training Only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the strength-training only group will take part in a 9-month exercise intervention at a local exercise facility. They will engage in strength training 3 days per week for approximately 60 minutes each exercise session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic Training Only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the aerobic training only group will take part in a 9-month exercise intervention at a local exercise facility. They will engage in aerobic training over 3 -5 days per week to achieve the targeted dose of 12 kcal/kg per week at a training intensity between 50-80% VO2 max.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination (Strength and Aerobic) Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the combination (strength and aerobic training) group will take part in a 9-month exercise intervention at a local exercise facility. They will engage aerobic training that will expend 10 kcal/kg/week in combination with strength-training, 3 days per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Intervention</intervention_name>
    <arm_group_label>Aerobic Training Only</arm_group_label>
    <arm_group_label>Combination (Strength and Aerobic) Training</arm_group_label>
    <arm_group_label>Strength Training Only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recent hemoglobin A1c result between 6.5%-13%&#xD;
&#xD;
          -  Diagnosis of Type 2 Diabetes Mellitus&#xD;
&#xD;
          -  BMI between 18.5 -25 kg/m2&#xD;
&#xD;
          -  Blood pressure &lt; 160/100&#xD;
&#xD;
          -  Sedentary lifestyle&#xD;
&#xD;
          -  Able and willing to enroll and meet requirements of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 30 years or greater than 75 years&#xD;
&#xD;
          -  Type 1 diabetes or use of insulin pump&#xD;
&#xD;
          -  Triglycerides &gt;500 mg/dL&#xD;
&#xD;
          -  Use of weight loss medication&#xD;
&#xD;
          -  Bariatric surgery&#xD;
&#xD;
          -  Consumes &gt;14 alcoholic drinks per week&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Plans to be away for more than four weeks&#xD;
&#xD;
          -  Medical conditions which would prevent long-term participation or which would&#xD;
             contraindicate physical activity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Latha Palaniappan, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Faroqi L, Bonde S, Goni DT, Wong CW, Wong M, Walai K, Araya S, Azamey S, Schreiner G, Bandy M, Raghuram SS, Mittal A, Mukherji A, Wangdak T, Talamoa R, Vera K, Nacif-Coelho C, Cde LG, Christensen M, Johannsen N, Haddad F, Moharir M, Palaniappan L. STRONG-D: Strength training regimen for normal weight diabetics: Rationale and design. Contemp Clin Trials. 2019 Mar;78:101-106. doi: 10.1016/j.cct.2019.01.005. Epub 2019 Jan 6.</citation>
    <PMID>30625372</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 6, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2015</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Latha Palaniappan, MD, MS</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

